BPC-157 is a 15-amino acid gastric peptide fragment that modulates nitric oxide and growth factor pathways
Specifications Description Research Overview Cagrilintide is a synthetic long-acting amylin analog developed for research into appetite regulation and metabolic pathways
10.1089/ars.2023.0492 48 IslamM
It is not a licensed medicine, is not approved for human or veterinary use, and must not be administered to any living organism outside a formally approved research protocol
Schizophrenia Schizophrenia is a chronic brain disorder characterized by distorted thinking, perceptions, emotions, language, sense of self, and behavior
Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant